Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The updated page shows only minor layout and wording adjustments without altering core study details, eligibility criteria, or reported results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:44:09.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T05:07:26.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:58:08.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No changes to core content, pricing, stock, or time slot information.
    Difference
    0.2%
    Check dated 2025-09-14T18:55:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T14:11:15.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while also removing specific location details and references to certain medical topics. Notably, the term 'Retinitis Pigmentosa' has been removed, which may impact the content's relevance to certain medical conditions.
    Difference
    2%
    Check dated 2025-08-31T11:42:01.000Z thumbnail image

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.